ADVERUM BIOTECHNOLOGIES INC's ticker is and the CUSIP is 00773U958. A total of 3 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $87,000 | -26.3% | 66,400 | -1.3% | 0.00% | – |
| Q4 2021 | $118,000 | +1375.0% | 67,300 | +1822.9% | 0.00% | – |
| Q3 2021 | $8,000 | -46.7% | 3,500 | -16.7% | 0.00% | – |
| Q2 2021 | $15,000 | -93.8% | 4,200 | -82.8% | 0.00% | – |
| Q1 2021 | $241,000 | -25.6% | 24,400 | -18.4% | 0.00% | -100.0% |
| Q4 2020 | $324,000 | +881.8% | 29,900 | +834.4% | 0.00% | – |
| Q3 2020 | $33,000 | -81.1% | 3,200 | -61.9% | 0.00% | -100.0% |
| Q2 2020 | $175,000 | +113.4% | 8,400 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $82,000 | +156.2% | 8,400 | +200.0% | 0.00% | – |
| Q4 2019 | $32,000 | -92.5% | 2,800 | -96.4% | 0.00% | -100.0% |
| Q3 2019 | $429,000 | +3.1% | 78,700 | +124.9% | 0.00% | -25.0% |
| Q2 2019 | $416,000 | +41500.0% | 35,000 | +17400.0% | 0.00% | – |
| Q1 2019 | $1,000 | -85.7% | 200 | -90.9% | 0.00% | – |
| Q4 2018 | $7,000 | -96.7% | 2,200 | -93.9% | 0.00% | -100.0% |
| Q1 2018 | $209,000 | +137.5% | 36,100 | +43.8% | 0.00% | +100.0% |
| Q4 2017 | $88,000 | +363.2% | 25,100 | +382.7% | 0.00% | – |
| Q3 2017 | $19,000 | +46.2% | 5,200 | 0.0% | 0.00% | – |
| Q2 2017 | $13,000 | -53.6% | 5,200 | -49.0% | 0.00% | – |
| Q1 2017 | $28,000 | -36.4% | 10,200 | -32.9% | 0.00% | – |
| Q4 2016 | $44,000 | +340.0% | 15,200 | +508.0% | 0.00% | – |
| Q3 2016 | $10,000 | -58.3% | 2,500 | -67.5% | 0.00% | – |
| Q2 2016 | $24,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |